SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001622627-23-000002
Filing Date
2023-02-14
Accepted
2023-02-13 17:53:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 CELLECTAR SC 13G/A rosalind_clrb_13ga3_02-13-23.htm SC 13G/A 90306
2 EXHIBIT JOINT FILING ex_a.htm EX-99.A BD-DIR-RESOL 2288
  Complete submission text file 0001622627-23-000002.txt   94251
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85798 | Film No.: 23620480
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A